Results 231 to 240 of about 124,779 (298)

Recombinant and Synthetic Vaccines

, 2007
openaire   +1 more source

Carbon Dots for Cancer Theranostics: Synthesis Strategies, Luminescence Properties, and Advances in Bioimaging‐Guided Diagnosis and Therapy

Chemistry – A European Journal, EarlyView.
Lighting up the path to precision oncology: This review comprehensively summarizes the rational design of carbon dots (CDs), elucidating how core size, surface chemistry, and heteroatom doping dictate their luminescence mechanisms. Special emphasis is placed on engineering NIR‐II emissive CDs for deep‐tissue imaging.
Zekun Yan, Yupeng Liu, Jinyun Tan, Songnan Qu   +3 more
wiley   +1 more source

Vaccination with an African Swine Fever Virus Multiepitope Protein Chitosan Nanoparticle-Based Subunit Vaccine Elicits Robust Immune Responses In Vivo. [PDF]

Vaccines (Basel)
Lee CM, Suresh R, Boley PA, Shekoni OC, Schrock J, Dolatyabi S, Singh M, Khatiwada S, Yadav KK, Bugybayeva D, Hanson J, Gourapura RJ, Kenney SP.   +12 more
europepmc   +1 more source

Chemical engineering as an essential element of industrial biotechnology in Mexico: New aims in research and university education

The Canadian Journal of Chemical Engineering, EarlyView.
Abstract On the centennial of higher education in Chemical Engineering in Mexico, it is pertinent to revisit the key stages that have contributed to its consolidation as a vital discipline for the nation's scientific and technological advancement. Although the initial mission of chemical engineering education was primarily oriented toward the training ...
Agustín López Munguía, Octavio T. Ramírez, Rafael Vazquez‐Duhalt, Eduardo Bárzana   +3 more
wiley   +1 more source

Next-generation neoantigen mRNA vaccines: Immuno-engineering strategies for precision cancer immunotherapy. [PDF]

Cell Oncol (Dordr)
Li X, Jabbarzadeh Kaboli P, Roozitalab G, Salahi S, Qian H, Zhang X, Chen K, Imani S.   +7 more
europepmc   +1 more source

Intravenous Lipopolysaccharide Challenge in Healthy Participants Reveals Pharmacodynamic Markers in Blood and Bone Marrow for Early‐Phase Oncology Drug Development

Clinical Pharmacology &Therapeutics, EarlyView.
Demonstrating pharmacological effects in early‐phase oncology clinical trials remains challenging, largely due to the lack of robust pharmacodynamic markers. Lipopolysaccharide (LPS) is used as an immune challenge agent in healthy participants to study drugs for autoimmune conditions.
Igor Radanović, Ingrid Tomljanović, Wieke H. Grievink, Diana R. Pereira, Michelle Osse, Peter van Balen, Maria J. Juachon, Marieke L. de Kam, Lisa Pagan, Manon A.A. Jansen, Matthijs Moerland, Jacobus J. Bosch   +11 more
wiley   +1 more source

Research progress of dengue virus T cell epitope mediated cellular immunity in avoiding ADE. [PDF]

Front Immunol
Ma M, Ye P, Pan J, Zhang Y, Yan W, Xu B, Ding J, Jiang L.   +7 more
europepmc   +1 more source

Novel Organelle‐Based Intracellular Immunity With Mechanistic and Therapeutic Implications

Barrier Immunity, EarlyView.
A conceptual framework illustrating how PAMPs/DAMPs initiate barrier, innate, adaptive, and intracellular immune responses, with organelle‐based intracellular immunity serving as a central integrator linking metabolism, inflammatory signaling, and therapeutic interventions to restore immune homeostasis.
Keman Xu, Shih‐Yu Hung, Fatma Saaoud, Ying Shao, Yifan Lu, Juanjuan Liu, Bo Yuan, Haiyan Xiang, Hong Wang, Xiaofeng Yang   +9 more
wiley   +1 more source

A computational framework for optimizing mRNA vaccine delivery via AI-guided nanoparticle design and <i>in silico</i> gene expression profiling. [PDF]

Front Immunol
Di Salvatore V, Cernuto F, Russo G, Pappalardo F.   +3 more
europepmc   +1 more source

StealthX: A Versatile and Potent Exosome-Based Vaccine Platform for the Next Pandemic. [PDF]

Vaccines (Basel)
Sun M, Elliott K.
europepmc   +1 more source